Marc-Oliver Grimm Selected Research

atraric acid

1/2022	The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2.
11/2014	A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc-Oliver Grimm Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 05/2002
30	Renal Cell Carcinoma (Grawitz Tumor) 09/2022 - 07/2009
13	Urinary Bladder Neoplasms (Bladder Cancer) 05/2022 - 02/2004
11	Prostatic Neoplasms (Prostate Cancer) 02/2022 - 05/2002
6	Neoplasm Metastasis (Metastasis) 07/2022 - 11/2004
5	Carcinoma (Carcinomatosis) 01/2022 - 01/2016
5	Non-Muscle Invasive Bladder Neoplasms 11/2021 - 01/2018
4	Transitional Cell Carcinoma 01/2022 - 02/2004
4	Disease Progression 01/2017 - 05/2004
3	Melanoma (Melanoma, Malignant) 01/2020 - 06/2017
2	Kidney Neoplasms (Kidney Cancer) 09/2022 - 01/2022
2	Lower Urinary Tract Symptoms 01/2018 - 05/2014
2	Overactive Urinary Bladder (Overactive Bladder) 01/2016 - 04/2010
1	Carcinogenesis 08/2021
1	Delayed Graft Function 06/2021
1	Neuroendocrine Carcinoma 09/2020
1	Fatigue 10/2019
1	Hypertension (High Blood Pressure) 10/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2019
1	Urologic Neoplasms (Urological Cancer) 09/2019
1	Body Weight (Weight, Body) 04/2018
1	Lymphatic Metastasis 01/2018
1	Obesity 01/2018
1	Drug-Related Side Effects and Adverse Reactions 06/2017
1	Clinical Deterioration 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2016
1	Urinary Retention 03/2016

Drug/Important Bio-Agent (IBA)

15	NivolumabIBA 09/2022 - 01/2017
10	Sunitinib (Sutent)FDA Link 01/2022 - 02/2010
9	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2017
8	IpilimumabIBA 01/2022 - 06/2017
7	Messenger RNA (mRNA)IBA 01/2021 - 05/2002
6	AndrogensIBA 02/2022 - 09/2014
6	Biomarkers (Surrogate Marker)IBA 05/2021 - 01/2017
5	Everolimus FDA Link 05/2021 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2005 - 05/2002
4	Pharmaceutical PreparationsIBA 11/2021 - 06/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 05/2008
2	B7-H1 AntigenIBA 01/2022 - 09/2019
2	atraric acidIBA 01/2022 - 11/2014
2	Telomerase (Telomerase Reverse Transcriptase)IBA 08/2021 - 05/2008
2	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2014
2	Biological ProductsIBA 01/2021 - 08/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2004
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 06/2016
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 09/2019
2	pazopanib FDA Link 01/2019 - 02/2010
2	Bevacizumab (Avastin)FDA Link 04/2018 - 02/2010
2	PlatinumIBA 01/2017 - 07/2009
2	ParaffinIBA 03/2014 - 05/2007
1	Complement System Proteins (Complement)IBA 09/2022
1	CateninsIBA 05/2022
1	Angiopoietin-2IBA 01/2022
1	sepantroniumIBA 01/2021
1	avelumabIBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Untranslated Regions (Untranslated Region)IBA 01/2021
1	3' Untranslated Regions (3' UTR)IBA 01/2021
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 09/2020
1	CXCR4 Receptors (CXCR4 Receptor)IBA 09/2020
1	Monoclonal AntibodiesIBA 09/2020
1	cyclopropapyrroloindoleIBA 01/2020
1	temsirolimus FDA Link 01/2020
1	Alanine Transaminase (SGPT)IBA 10/2019
1	Amylases FDA Link 10/2019
1	Lipase (Acid Lipase)FDA Link 10/2019
1	Immune Checkpoint ProteinsIBA 09/2019
1	AntibodiesIBA 09/2019
1	Blocking AntibodiesIBA 09/2019
1	A-Form DNA (A-DNA)IBA 04/2019
1	Kisspeptin-1 ReceptorsIBA 04/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2019
1	lenvatinibIBA 04/2018
1	atezolizumabIBA 04/2018
1	cabozantinibIBA 04/2018
1	tivozanibIBA 04/2018
1	HydrogelsIBA 01/2018
1	Keratin-20 (Cytokeratin 20)IBA 09/2017
1	Insulin-Like PeptidesIBA 09/2017
1	Immunoglobulin G (IgG)IBA 01/2017
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2016

Therapy/Procedure

23	Therapeutics 09/2022 - 04/2010
6	Cystectomy 11/2021 - 05/2007
4	Nephrectomy 01/2022 - 07/2009
2	Immunotherapy 01/2022 - 04/2018
2	Castration 01/2022 - 08/2021
2	Intravesical Administration 11/2021 - 11/2020
2	Kidney Transplantation 06/2021 - 03/2016
2	Urinary Diversion (Ileal Conduit) 01/2018 - 03/2015
2	Drug Therapy (Chemotherapy) 01/2017 - 07/2009
2	Transurethral Resection of Prostate (TURP) 03/2016 - 05/2014
2	Lasers (Laser) 09/2011 - 07/2009
1	Lymph Node Excision (Lymph Node Dissection) 07/2022
1	Prostatectomy (Retropubic Prostatectomy) 07/2022
1	Sutures (Suture) 07/2022
1	Conservative Treatment 11/2021
1	Investigational Therapies (Experimental Therapy) 01/2021
1	Microspheres (Microsphere) 01/2018
1	Neoadjuvant Therapy 01/2017
1	Retreatment 01/2016